Clinical Trial Update: Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating LY01005 versus ZOLADEX in prostate cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• LY01005
• Zoladex (goserelin)

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED